All In Biotech

Drug Trial Radar · NCT07003425

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

May 14, 2025

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
Apogee Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jun 4, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an APG777 Parent Study (NCT06395948). The LTE study will consist of 3 periods: 1) Screening Visit will coincide with the last visit of the Maintenance Period in the Parent Study 2) Extended Treatment Period 3) Post-treatment Follow-up Period. This study will be conducted in participants with atopic dermatitis (AD) who completed the Treatment Period in a prior APG777 study and who, in the opinion of the Investigator, would benefit from long-term treatment with APG777.

Conditions

  • Atopic Dermatitis

Interventions

  • APG777Drug

    APG777 subcutaneous injection

  • APG777Drug

    APG777 subcutaneous injection every 12 weeks

  • APG777Drug

    APG777 subcutaneous injection every 24 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment Emergent Adverse EventsTime frame: Up to 3 years

Locations

80 sites in 9 countries. Site status is shown where the registry gives one.

  • Investigational Site

    Fountain Valley, California · Recruiting

  • Investigational Site

    Los Angeles, California · Recruiting

  • Investigational Site

    Coral Gables, Florida · Recruiting

  • Investigational Site

    Jacksonville, Florida · Recruiting

  • Investigational Site

    Margate, Florida · Recruiting

  • Investigational Site

    Douglasville, Georgia · Recruiting

  • Investigational Site

    Skokie, Illinois · Recruiting

  • Investigational Site

    Bowling Green, Kentucky · Recruiting

  • Investigational Site

    Rockville, Maryland · Recruiting

  • Investigational Site

    Detroit, Michigan · Recruiting

  • Investigational Site

    Troy, Michigan · Recruiting

  • Investigational Site

    New York, New York · Recruiting

  • Investigational Site

    Wilmington, North Carolina · Recruiting

  • Investigational Site

    Boardman, Ohio · Recruiting

  • Investigational Site

    Mason, Ohio · Recruiting

  • Investigational Site

    Portland, Oregon · Recruiting

  • Investigational Site

    Pittsburgh, Pennsylvania · Recruiting

  • Investigational Site

    Charleston, South Carolina · Recruiting

  • Investigational Site

    Nashville, Tennessee · Recruiting

  • Investigational Site

    Dallas, Texas · Recruiting

  • Investigational Site

    Frisco, Texas · Recruiting

  • Investigational Site

    San Antonio, Texas · Recruiting

  • Investigational Site

    Mill Creek, Washington · Recruiting

  • Investigational Site

    Calgary, Alberta, Canada · Recruiting

  • Investigational Site

    Calgary, Alberta, Canada · Recruiting

  • Investigational Site

    Edmonton, Alberta, Canada · Recruiting

  • Investigational Site

    Vancouver, British Columbia, Canada · Recruiting

  • Investigational Site

    Fredericton, Brunswick, Canada · Recruiting

  • Investigational Site

    Ajax, Ontario, Canada · Recruiting

  • Investigational Site

    Markham, Ontario, Canada · Recruiting

  • Investigational Site

    Mississauga, Ontario, Canada · Recruiting

  • Investigational Site

    Ottawa, Ontario, Canada · Recruiting

  • Investigational Site

    Peterborough, Ontario, Canada · Recruiting

  • Investigational Site

    Toronto, Ontario, Canada · Recruiting

  • Investigational Site

    Toronto, Ontario, Canada · Recruiting

  • Investigational Site

    Toronto, Ontario, Canada · Recruiting

  • Investigational Site

    Montreal, Quebec, Canada · Recruiting

  • Investigational Site

    Québec, Quebec, Canada · Recruiting

  • Investigational Site

    Prague, Czechia · Recruiting

  • Investigational Site

    Prague, Czechia · Recruiting

Showing 40 of 80 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.